| abstract |
(57) [Summary]nThe present invention includes viral vectors used to transduce a target cell, ie, to introduce genetic material into the cell. Target cells of interest are eukaryotic cells, especially human cells. Transduction can be performed in vivo or in vitro. More particularly, the invention relates to viral vectors having a chimeric envelope protein comprising the IgG binding domain of Protein A. These vectors are particularly useful for gene therapy when used with antibodies that target specific cells. |